Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Unknown 2

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Small Cell Lung Carcinoma 3Rectal Neoplasms 3Colorectal Neoplasms 3Polycystic Ovary Syndrome 2Colonic Neoplasms 2Urinary Bladder Neoplasms 1Stomach Neoplasms 1Sprains and Strains 1Sepsis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Insulin Resistance 1Febrile Neutropenia 1Breast Neoplasms 1

Interventions

Fluorouracil 34Leucovorin 31Oxaliplatin 25Irinotecan 19Capecitabine 13Folfox protocol 11Chemotherapy, Adjuvant 11Cetuximab 11Bevacizumab 9Neoadjuvant Therapy 8XELOX 7Laparoscopy 7Drug Therapy 7Endoscopic Mucosal Resection 5Colonoscopy 5Surgical Procedures, Operative 4Gemcitabine 4Tegafur 3Radiotherapy 3Propofol 3Preoperative Exercise 3Panitumumab 3Fentanyl 3Curcumin 3Colectomy 3Celecoxib 3Aspirin 3raltitrexed 2Surveys and Questionnaires 2Sodium Chloride 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Colonic Neoplasms × Simvastatin × Clear all
NCT01110785 2013-09-17

Simvastatin and Panitumumab in Treating Patients With Advanced or Metastatic Colorectal Cancer

National Cancer Institute (NCI)

Phase 2 Unknown
46 enrolled
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT01190462 2013-08-12

Cetuximab and Simvastatin in Treating Patients With Advanced or Metastatic Colorectal Cancer

National Cancer Institute (NCI)

Phase 2 Unknown
51 enrolled
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡